Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides. - Wikidata - awgldk - TriplyDB

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

http://www.wikidata.org/entity/Q33320228

about

A cyclic undecamer peptide mimics a turn in folded Alzheimer amyloid β and elicits antibodies against oligomeric and fibrillar amyloid and plaques Supramolecular Hydrogelators and Hydrogels: From Soft Matter to Molecular Biomaterials.A self-assembling peptide acting as an immune adjuvant.Evaluation of an α synuclein sensitized dendritic cell based vaccine in a transgenic mouse model of Parkinson disease Global antibody response to Staphylococcus aureus live-cell vaccination Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.Effect of Cinnamomum Verum Extract on the Amyloid Formation of Hen Egg-white Lysozyme and Study of its Possible Role in Alzheimer's Disease.Dendritic and Langerhans cells respond to Aβ peptides differently: implication for AD immunotherapy Vaccination induced changes in pro-inflammatory cytokine levels as an early putative biomarker for cognitive improvement in a transgenic mouse model for Alzheimer disease.Perspectives in molecular imaging using staging biomarkers and immunotherapies in Alzheimer's disease.

P2860

Q28740910-3957627B-4ECE-4D5F-A0C0-D73A2FC08290 Q30781853-455C89F1-5B51-4F64-9213-F888D574955A Q33640064-5E04962F-2CD0-4CAB-B4CB-5580482633E9 Q35887768-32BBBDAC-F343-432F-816E-4C80DA57826B Q36824281-0AE1C778-BC8B-4748-85F6-6FAD8FBE719F Q37357276-C8D142FE-4639-42BA-BEBA-6CCB664FDCC1 Q38259182-BAB7B36A-2EC5-41B0-BB2E-C6A8154D2D4D Q38262675-7D5501E1-8FC9-4FAC-9888-7B2B1B2EA9E7 Q41825729-D26D8660-557E-410F-8E6F-3009054CB705 Q51481172-EB395C11-A54B-48CF-AD8A-3ADF727DEE1B

P2860

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

http://www.wikidata.org/entity/Q33320228

description

2008 nî lūn-bûn

@nan

2008 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@ast

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@en

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@nl

type

label

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@ast

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@en

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@nl

prefLabel

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@ast

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@en

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@nl

P1433

Q33320228-5319EBFB-36EC-4E72-8204-CAC9D6658457

P1476

Q33320228-40247273-41F9-42E7-8EE2-41664ECF3FAB

P2093

Q33320228-5D944BED-E7CB-4A1B-A850-419A24FE62A5

Q33320228-8048531A-10CF-48E6-8BCA-DF26AD2473A8

Q33320228-AB12F9F0-CA1A-4AB1-8693-5B67C2537C53

Q33320228-DDA611BD-8C85-41D1-8C8A-A626E3DE923B

Q33320228-FEAE38B0-D88D-4B75-8A27-2E5B16C0EB04

P2860

Q33320228-07538749-8DEE-4D88-A9AB-36B9C7F415B2

Q33320228-0C99D580-1CF5-4813-AB1C-764EC18A7DBB

Q33320228-0E146266-27BC-4972-BBF2-FF5CBBFE2BA8

Q33320228-14927CBB-436A-430E-8E4C-02501902ACD5

Q33320228-2439484F-0BA9-4C1B-B707-001492768E28

Q33320228-29902FE9-AF71-4A3F-B4B2-52566666B828

Q33320228-3607270D-A6D1-48B9-95F5-31C0D0373E36

Q33320228-404F4C15-D8E0-4CEC-B5F2-294466CBC8A0

Q33320228-40F40A9D-E435-41B3-BE4D-F112B9D45E2A

Q33320228-42AD78B2-DFD9-4019-B161-6AEBD61BD395

P2888

Q33320228-7E8091B1-E5EB-46AC-9DAE-8A49D1187DD7

P304

Q33320228-C345A151-4695-49A8-B4AC-B9441146E90E

P31

Q33320228-FD04CD69-8A63-4831-9C24-F08911081F7C

P356

Q33320228-A1BC027E-A800-4C8F-9AC4-1C3E385F41CD

P478

Q33320228-9E9AB376-720D-410E-A1F0-88C05A8AF607

P577

Q33320228-0FF896EB-5760-45C7-B31B-F582792838E3

P5875

Q33320228-D025C36B-1727-42BF-B5D7-2030B36951E8

P6179

Q33320228-C99CBF87-2632-4C26-AA99-486D8D4A370E

P698

Q33320228-A0D336A2-8C94-4567-AF43-C9FF62DCFAD9

P932

Q33320228-BAEF4225-2F9E-4EDC-876A-0381161239B2

P356

P1433

BMC Neuroscience

P1476

Successful adjuvant-free vaccination of BALB/c mice with mutated amyloid beta peptides.

@en

P2093

Chuanhai Cao

http://www.w3.org/2001/XMLSchema#string

Eugene A Jackson

http://www.w3.org/2001/XMLSchema#string

Huntington Potter

http://www.w3.org/2001/XMLSchema#string

Monika M Wahi

http://www.w3.org/2001/XMLSchema#string

Xiaoyang Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

Adjuvants and antibody production: dispelling the myths associated with Freund's complete and other adjuvants

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease.

Inflammatory pathogenesis in Alzheimer's disease: biological mechanisms and cognitive sequeli.

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

A second-generation vaccine protects against the psychoactive effects of cocaine.

Structure-function analysis of the epitope for 4E10, a broadly neutralizing human immunodeficiency virus type 1 antibody.

P2888

P304

25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1471-2202-9-25

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5570485

http://www.w3.org/2001/XMLSchema#string

P6179

1000079465

http://www.w3.org/2001/XMLSchema#string

P698

18282292

http://www.w3.org/2001/XMLSchema#string

P932

2270279

http://www.w3.org/2001/XMLSchema#string